A phenotypic spectrum of autism is attributable to the combined effects of rare variants, polygenic risk and sex.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
09 2022
Historique:
received: 25 02 2021
accepted: 28 03 2022
pubmed: 3 6 2022
medline: 16 9 2022
entrez: 2 6 2022
Statut: ppublish

Résumé

The genetic etiology of autism spectrum disorder (ASD) is multifactorial, but how combinations of genetic factors determine risk is unclear. In a large family sample, we show that genetic loads of rare and polygenic risk are inversely correlated in cases and greater in females than in males, consistent with a liability threshold that differs by sex. De novo mutations (DNMs), rare inherited variants and polygenic scores were associated with various dimensions of symptom severity in children and parents. Parental age effects on risk for ASD in offspring were attributable to a combination of genetic mechanisms, including DNMs that accumulate in the paternal germline and inherited risk that influences behavior in parents. Genes implicated by rare variants were enriched in excitatory and inhibitory neurons compared with genes implicated by common variants. Our results suggest that a phenotypic spectrum of ASD is attributable to a spectrum of genetic factors that impact different neurodevelopmental processes.

Identifiants

pubmed: 35654974
doi: 10.1038/s41588-022-01064-5
pii: 10.1038/s41588-022-01064-5
pmc: PMC9474668
mid: NIHMS1793519
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1284-1292

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH113715
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH124847
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH119738
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH119746
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Sebat, J. et al. Strong association of de novo copy number mutations with autism. Science 316, 445–449 (2007).
pubmed: 17363630 pmcid: 2993504 doi: 10.1126/science.1138659
Iossifov, I. et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216–221 (2014).
pubmed: 25363768 pmcid: 4313871 doi: 10.1038/nature13908
Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431–444 (2019).
pubmed: 30804558 pmcid: 6454898 doi: 10.1038/s41588-019-0344-8
Sebat, J., Levy, D. L. & McCarthy, S. E. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 25, 528–535 (2009).
pubmed: 19883952 pmcid: 3351381 doi: 10.1016/j.tig.2009.10.004
Bergen, S. E. et al. Joint contributions of rare copy number variants and common SNPs to risk for schizophrenia. Am. J. Psychiatry 176, 29–35 (2019).
pubmed: 30392412 doi: 10.1176/appi.ajp.2018.17040467
Davies, R. W. et al. Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome. Nat. Med. 26, 1912–1918 (2020).
pubmed: 33169016 pmcid: 7975627 doi: 10.1038/s41591-020-1103-1
Lim, E. T. et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 77, 235–242 (2013).
pubmed: 23352160 pmcid: 3613849 doi: 10.1016/j.neuron.2012.12.029
Zhao, X. et al. A unified genetic theory for sporadic and inherited autism. Proc. Natl Acad. Sci. USA 104, 12831–12836 (2007).
pubmed: 17652511 pmcid: 1933261 doi: 10.1073/pnas.0705803104
Werling, D. M. & Geschwind, D. H. Recurrence rates provide evidence for sex-differential, familial genetic liability for autism spectrum disorders in multiplex families and twins. Mol. Autism 6, 27 (2015).
pubmed: 25973164 pmcid: 4429923 doi: 10.1186/s13229-015-0004-5
Robinson, E. B., Lichtenstein, P., Anckarsater, H., Happe, F. & Ronald, A. Examining and interpreting the female protective effect against autistic behavior. Proc. Natl Acad. Sci. USA 110, 5258–5262 (2013).
pubmed: 23431162 pmcid: 3612665 doi: 10.1073/pnas.1211070110
Sanders, S. J. et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 87, 1215–1233 (2015).
pubmed: 26402605 pmcid: 4624267 doi: 10.1016/j.neuron.2015.09.016
Desachy, G. et al. Increased female autosomal burden of rare copy number variants in human populations and in autism families. Mol. Psychiatry 20, 170–175 (2015).
pubmed: 25582617 doi: 10.1038/mp.2014.179
Jacquemont, S. et al. A higher mutational burden in females supports a ‘female protective model’ in neurodevelopmental disorders. Am. J. Hum. Genet. 94, 415–425 (2014).
pubmed: 24581740 pmcid: 3951938 doi: 10.1016/j.ajhg.2014.02.001
De Rubeis, S. et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209–215 (2014).
pubmed: 25363760 pmcid: 4402723 doi: 10.1038/nature13772
Brandler, W. M. et al. Paternally inherited cis-regulatory structural variants are associated with autism. Science 360, 327–331 (2018).
pubmed: 29674594 pmcid: 6449150 doi: 10.1126/science.aan2261
Krumm, N. et al. Excess of rare, inherited truncating mutations in autism. Nat. Genet. 47, 582–588 (2015).
pubmed: 25961944 pmcid: 4449286 doi: 10.1038/ng.3303
Weiner, D. J. et al. Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders. Nat. Genet. 49, 978–985 (2017).
pubmed: 28504703 pmcid: 5552240 doi: 10.1038/ng.3863
Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431–444 (2019).
pubmed: 30804558 pmcid: 6454898 doi: 10.1038/s41588-019-0344-8
Spark Consortium. SPARK: a US cohort of 50,000 families to accelerate autism research. Neuron 97, 488–493 (2018).
doi: 10.1016/j.neuron.2018.01.015
Lloyd-Jones, L. R. et al. Improved polygenic prediction by Bayesian multiple regression on summary statistics. Nat. Commun. 10, 5086 (2019).
pubmed: 31704910 pmcid: 6841727 doi: 10.1038/s41467-019-12653-0
Werling, D. M. The role of sex-differential biology in risk for autism spectrum disorder. Biol. Sex. Differ. 7, 58 (2016).
pubmed: 27891212 pmcid: 5112643 doi: 10.1186/s13293-016-0112-8
Falconer, D. S. Inheritance of liability to certain diseases estimated from incidence among relatives. Ann. Hum. Genet. 29, 51–76 (1965).
doi: 10.1111/j.1469-1809.1965.tb00500.x
Reich, T., Morris, C. A. & James, J. W. Use of multiple thresholds in determining mode of transmission of semi-continuous traits. Ann. Hum. Genet. 36, 163 (1972).
pubmed: 4676360 doi: 10.1111/j.1469-1809.1972.tb00767.x
Antaki, D. et al. A phenotypic spectrum of autism is attributable to the combined effects of rare variants, polygenic risk and sex. Preprint at medRxiv https://doi.org/2021.03.30.21254657 (2021).
Robinson, E. B. et al. Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population. Nat. Genet. 48, 552–555 (2016).
pubmed: 26998691 pmcid: 4986048 doi: 10.1038/ng.3529
Buja, A. et al. Damaging de novo mutations diminish motor skills in children on the autism spectrum. Proc. Natl Acad. Sci. USA 115, E1859–E1866 (2018).
pubmed: 29434036 pmcid: 5828599 doi: 10.1073/pnas.1715427115
Satterstrom, F. K. et al. Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell 180, 568–584.e23 (2020).
pubmed: 31981491 pmcid: 7250485 doi: 10.1016/j.cell.2019.12.036
Michaelson, J. J. et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 151, 1431–1442 (2012).
pubmed: 23260136 pmcid: 3712641 doi: 10.1016/j.cell.2012.11.019
Kong, A. et al. Rate of de novo mutations and the importance of father’s age to disease risk. Nature 488, 471–475 (2012).
pubmed: 22914163 pmcid: 3548427 doi: 10.1038/nature11396
Goriely, A. & Wilkie, A. O. Missing heritability: paternal age effect mutations and selfish spermatogonia. Nat. Rev. Genet. 11, 589 (2010).
pubmed: 20634812 doi: 10.1038/nrg2809-c1
Gratten, J. et al. Risk of psychiatric illness from advanced paternal age is not predominantly from de novo mutations. Nat. Genet. 48, 718–724 (2016).
pubmed: 27213288 doi: 10.1038/ng.3577
Mullins, N. et al. Reproductive fitness and genetic risk of psychiatric disorders in the general population. Nat. Commun. 8, 15833 (2017).
pubmed: 28607503 pmcid: 5474730 doi: 10.1038/ncomms15833
He, X. et al. Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes. PLoS Genet. 9, e1003671 (2013).
pubmed: 23966865 pmcid: 3744441 doi: 10.1371/journal.pgen.1003671
Li, M. et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science 362, eaat7615 (2018).
Polioudakis, D. et al. A single-cell transcriptomic atlas of human neocortical development during mid-gestation. Neuron 103, 785–801.e8 (2019).
pubmed: 31303374 pmcid: 6831089 doi: 10.1016/j.neuron.2019.06.011
Wainschtein, P. et al. Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data. Nat. Genet. 54, 263–273 (2022).
pubmed: 35256806 pmcid: 9119698 doi: 10.1038/s41588-021-00997-7
Turner, T. N. et al. Sex-based analysis of de novo variants in neurodevelopmental disorders. Am. J. Hum. Genet. 105, 1274–1285 (2019).
pubmed: 31785789 pmcid: 6904808 doi: 10.1016/j.ajhg.2019.11.003
Russell, G., Steer, C. & Golding, J. Social and demographic factors that influence the diagnosis of autistic spectrum disorders. Soc. Psychiatry Psychiatr. Epidemiol. 46, 1283–1293 (2011).
pubmed: 20938640 doi: 10.1007/s00127-010-0294-z
Werling, D. M. & Geschwind, D. H. Sex differences in autism spectrum disorders. Curr. Opin. Neurol. 26, 146–153 (2013).
pubmed: 23406909 pmcid: 4164392 doi: 10.1097/WCO.0b013e32835ee548
D’Angelo, D. et al. Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities. JAMA Psychiatry 73, 20–30 (2016).
pubmed: 26629640 pmcid: 5894477 doi: 10.1001/jamapsychiatry.2015.2123
Malaspina, D. et al. Paternal age and intelligence: implications for age-related genomic changes in male germ cells. Psychiatr. Genet. 15, 117–125 (2005).
pubmed: 15900226 doi: 10.1097/00041444-200506000-00008
Lyall, K. et al. The association between parental age and autism-related outcomes in children at high familial risk for autism. Autism Res. 13, 998–1010 (2020).
pubmed: 32314879 pmcid: 7396152 doi: 10.1002/aur.2303
Frans, E. M. et al. Autism risk across generations: a population-based study of advancing grandpaternal and paternal age. JAMA Psychiatry 70, 516–521 (2013).
pubmed: 23553111 pmcid: 3701020 doi: 10.1001/jamapsychiatry.2013.1180
Lampi, K. M. et al. Parental age and risk of autism spectrum disorders in a Finnish national birth cohort. J. Autism Dev. Disord. 43, 2526–2535 (2013).
pubmed: 23479075 doi: 10.1007/s10803-013-1801-3
Lundstrom, S. et al. Trajectories leading to autism spectrum disorders are affected by paternal age: findings from two nationally representative twin studies. J. Child Psychol. Psychiatry 51, 850–856 (2010).
pubmed: 20214699 doi: 10.1111/j.1469-7610.2010.02223.x
Fulco, C. J., Henry, K. L., Rickard, K. M. & Yuma, P. J. Time-varying outcomes associated with maternal age at first birth. J. Child Fam. Stud. 29, 1537–1547 (2020).
doi: 10.1007/s10826-019-01616-0
Boyle, E. A., Li, Y. I. & Pritchard, J. K. An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177–1186 (2017).
pubmed: 28622505 pmcid: 5536862 doi: 10.1016/j.cell.2017.05.038
Liu, X., Li, Y. I. & Pritchard, J. K. Trans effects on gene expression can drive omnigenic inheritance. Cell 177, 1022–1034.e6 (2019).
pubmed: 31051098 pmcid: 6553491 doi: 10.1016/j.cell.2019.04.014
Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190–1195 (2012).
pubmed: 22955828 pmcid: 3771521 doi: 10.1126/science.1222794
Jacquemont, S. et al. Genes to mental health (G2MH): a framework to map the mombined effects of rare and common variants on dimensions of cognition and psychopathology. Am. J. Psychiatry 179, 189–203 (2022).
pubmed: 35236119 doi: 10.1176/appi.ajp.2021.21040432
Brandler, W. M. et al. Paternally inherited cis-regulatory structural variants are associated with autism. Science 360, 327–331 (2018).
pubmed: 29674594 pmcid: 6449150 doi: 10.1126/science.aan2261
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
pubmed: 17701901 pmcid: 1950838 doi: 10.1086/519795
Lam, M. et al. RICOPILI: Rapid Imputation for COnsortias PIpeLIne. Bioinformatics 36, 930–933 (2020).
pubmed: 31393554 doi: 10.1093/bioinformatics/btz633
Lee, J. J. et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat. Genet. 50, 1112–1121 (2018).
pubmed: 30038396 pmcid: 6393768 doi: 10.1038/s41588-018-0147-3
Choi, S. W. & O’Reilly, P. F. PRSice-2: polygenic risk score software for biobank-scale data. Gigascience 8, giz082 (2019).
pubmed: 31307061 pmcid: 6629542 doi: 10.1093/gigascience/giz082
Lian, A., Guevara, J., Xia, K. & Sebat, J. Customized de novo mutation detection for any variant calling pipeline: SynthDNM. Bioinformatics 37, 3640–3641 (2021).
pmcid: 8545295 doi: 10.1093/bioinformatics/btab225
Feliciano, P. et al. Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes. npj Genom. Med. 4, 19 (2019).
pubmed: 31452935 pmcid: 6707204 doi: 10.1038/s41525-019-0093-8
Antaki, D., Brandler, W. M. & Sebat, J. SV2: accurate structural variation genotyping and de novo mutation detection from whole genomes. Bioinformatics 34, 1774–1777 (2018).
pubmed: 29300834 doi: 10.1093/bioinformatics/btx813
Samocha, K. E. et al. Regional missense constraint improves variant deleteriousness prediction. Preprint at bioRxiv (2017).
Kosmicki, J. A. et al. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Nat. Genet. 49, 504–510 (2017).
pubmed: 28191890 pmcid: 5496244 doi: 10.1038/ng.3789
Brainstorm Consortium et al. Analysis of shared heritability in common disorders of the brain. Science 360, eaap8757 (2018).
doi: 10.1126/science.aap8757
Hagenaars, S. P. et al. Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (N = 112 151) and 24 GWAS consortia. Mol. Psychiatry 21, 1624–1632 (2016).
pubmed: 26809841 pmcid: 5078856 doi: 10.1038/mp.2015.225
Clarke, T. K. et al. Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general population. Mol. Psychiatry 21, 419–425 (2016).
pubmed: 25754080 doi: 10.1038/mp.2015.12
Samocha, K. E. et al. A framework for the interpretation of de novo mutation in human disease. Nat. Genet. 46, 944–950 (2014).
pubmed: 25086666 pmcid: 4222185 doi: 10.1038/ng.3050
Sey, N. Y. A. et al. A computational tool (H-MAGMA) for improved prediction of brain-disorder risk genes by incorporating brain chromatin interaction profiles. Nat. Neurosci. 23, 583–593 (2020).
pubmed: 32152537 pmcid: 7131892 doi: 10.1038/s41593-020-0603-0
Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202–1214 (2015).
pubmed: 26000488 pmcid: 4481139 doi: 10.1016/j.cell.2015.05.002
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
pubmed: 29608179 pmcid: 6700744 doi: 10.1038/nbt.4096

Auteurs

Danny Antaki (D)

Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, USA.
Beyster Center for Psychiatric Genomics, University of California San Diego, La Jolla, CA, USA.
Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.

James Guevara (J)

Beyster Center for Psychiatric Genomics, University of California San Diego, La Jolla, CA, USA.
Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.

Adam X Maihofer (AX)

Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.

Marieke Klein (M)

Beyster Center for Psychiatric Genomics, University of California San Diego, La Jolla, CA, USA.
Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.

Madhusudan Gujral (M)

Beyster Center for Psychiatric Genomics, University of California San Diego, La Jolla, CA, USA.
Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.

Jakob Grove (J)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Center for Genomics and Personalized Medicine and Center for Integrative Sequencing, iSEQ, Aarhus, Denmark.
Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.

Caitlin E Carey (CE)

Harvard T.H. Chan School of Public Health, Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.

Oanh Hong (O)

Beyster Center for Psychiatric Genomics, University of California San Diego, La Jolla, CA, USA.
Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.

Maria J Arranz (MJ)

Research Laboratory Unit, Fundacio Docencia i Recerca Mutua, Terrassa, Spain.

Amaia Hervas (A)

Child and Adolescent Mental Health Unit, Hospital Universitari Mútua de Terrassa, Barcelona, Spain.

Christina Corsello (C)

TEACCH Autism Program, University of North Carolina, Chapel Hill, NC, USA.

Keith K Vaux (KK)

Human Longevity Inc., San Diego, CA, USA.

Alysson R Muotri (AR)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Pediatrics and Department of Cellular & Molecular Medicine, University of California San Diego, School of Medicine, Center for Academic Research and Training in Anthropogeny, Archealization Center, Kavli Institute for Brain and Mind, La Jolla, CA, USA.

Lilia M Iakoucheva (LM)

Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA.

Eric Courchesne (E)

Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.
Autism Center of Excellence, University of California San Diego, La Jolla, CA, USA.

Karen Pierce (K)

Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.
Autism Center of Excellence, University of California San Diego, La Jolla, CA, USA.

Joseph G Gleeson (JG)

Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Neurosciences, University of California San Diego, La Jolla, CA, USA.

Elise B Robinson (EB)

Harvard T.H. Chan School of Public Health, Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.

Caroline M Nievergelt (CM)

Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.

Jonathan Sebat (J)

Beyster Center for Psychiatric Genomics, University of California San Diego, La Jolla, CA, USA. jsebat@ucsd.edu.
Department of Psychiatry, University of California San Diego, La Jolla, CA, USA. jsebat@ucsd.edu.
Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA. jsebat@ucsd.edu.
Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA. jsebat@ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH